Innovation in healthcare rarely happens in isolation. Pharmaceutical companies, biotechnology firms, technology developers, research organizations, and healthcare providers increasingly work together to advance therapies, technologies, and commercial opportunities.
For companies pursuing external innovation, one of the first and most important questions is: Who should we partner with?
Answering this question requires a comprehensive understanding of the market, available assets, company capabilities, development programs, strategic priorities, and partnership history. A long list of companies does not necessarily translate into a useful partnership pipeline.
Healthcare Partner Identification Services address this challenge by helping organizations systematically identify and prioritize companies that match defined partnership objectives.
For pharmaceutical and biotechnology companies, these services can support licensing searches, co-development opportunities, technology collaborations, commercial alliances, and strategic expansion.
DelveInsight's partner identification framework emphasizes defining the partnership area, evaluating assets and technologies, developing partnering hypotheses, prioritizing leads, and assessing the prospective partner's interest.
Partner identification should not be viewed as a simple market research exercise. It is closely connected to corporate strategy and business development.
A company looking to expand its portfolio may need a different partner profile from an organization seeking a regional commercialization partner. Similarly, a company searching for a technology platform will have different evaluation criteria from one looking for a late-stage pharmaceutical asset.
Therefore, the partner search should begin with a clear understanding of the business objective.
Potential objectives may include: